Advita Ortho obtained three novel intellectual property applications from Bauer Innovations that expand Advita’s growing Equinoxe Shoulder System portfolio, extending its capabilities to treat patients with glenoid bone loss using reverse total shoulder arthroplasty (rTSA).
These technologies will facilitate new advances in reverse shoulder arthroplasty implant design. Advita intends to implement these patents to design new reverse shoulder glenoid baseplates that better support revision shoulder arthroplasty by improving glenoid fixation in patients with central vault defects and uncontained glenoid defects.
“This important acquisition will help expand Advita’s portfolio of innovative Equinoxe Shoulder System solutions, allowing us to develop a next-generation rTSA glenoid revision baseplate system that enables surgeons to treat their most difficult glenoid bone loss patients in a more efficient manner,” said Chris Roche, Advita’s Senior Vice President of Extremities. “This investment facilitates development of a revision rTSA glenoid baseplate that will be able to address practically any size or shape glenoid defect, using an off-the-shelf component.”
Advita Ortho obtained three novel intellectual property applications from Bauer Innovations that expand Advita's growing Equinoxe Shoulder System portfolio, extending its capabilities to treat patients with glenoid bone loss using reverse total shoulder arthroplasty (rTSA).
These technologies will facilitate new advances in reverse...
Advita Ortho obtained three novel intellectual property applications from Bauer Innovations that expand Advita’s growing Equinoxe Shoulder System portfolio, extending its capabilities to treat patients with glenoid bone loss using reverse total shoulder arthroplasty (rTSA).
These technologies will facilitate new advances in reverse shoulder arthroplasty implant design. Advita intends to implement these patents to design new reverse shoulder glenoid baseplates that better support revision shoulder arthroplasty by improving glenoid fixation in patients with central vault defects and uncontained glenoid defects.
“This important acquisition will help expand Advita’s portfolio of innovative Equinoxe Shoulder System solutions, allowing us to develop a next-generation rTSA glenoid revision baseplate system that enables surgeons to treat their most difficult glenoid bone loss patients in a more efficient manner,” said Chris Roche, Advita’s Senior Vice President of Extremities. “This investment facilitates development of a revision rTSA glenoid baseplate that will be able to address practically any size or shape glenoid defect, using an off-the-shelf component.”
Copy to clipboard 
